Consistent over-reporting of product use limits researchers’ ability to accurately measure adherence and estimate product efficacy in HIV prevention trials. While lying is a universal characteristic of the human condition, growing evidence of a stark discrepancy between self-reported product use and biologic or pharmacokinetic evidence demands examination of the reasons research participants frequently misrepresent product use in order to mitigate this challenge in future research. This study (VOICE-D) was an ancillary post-trial study of the vaginal and oral interventions to control the epidemic (VOICE) phase IIb trial (MTN 003). It was conducted in three African countries to elicit candid accounts from former VOICE trial participants abou...
Oral emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) has been evaluated as pre-exposure prophy...
Low adherence in vaginal microbicide clinical trials for HIV prevention has impeded interpretation o...
The Author(s) 2014. This article is published with open access at Springerlink.com Abstract Oral emt...
Accurate estimates of study product use are critical to understanding and addressing adherence chall...
Accurate estimates of study product use are critical to understanding and addressing adherence chall...
Objectives: In VOICE, a phase IIB trial of daily oral and vaginal tenofovir for HIV prevention, at l...
VOICE—a phase 2B, placebo-controlled, randomized trial testing daily use of an antiretroviral tablet...
BackgroundInterpretation of clinical trial results testing vaginal microbicide gels for HIV preventi...
This mixed-methods study used qualitative interviews to explore discrepancies between self-reported ...
Background Subjects who enroll in multiple studies have been found to use decep-tion at times to ove...
High levels of adherence in clinical trials are essential for producing accurate intervention effica...
Disclosure, or open communication, by female microbicide trial participants of their trial participa...
The goal of this study was to explore patterns and explanations of adherence to antiretroviral thera...
Misreporting of adherence undermines detection of an association between product use and HIV infecti...
High levels of adherence in clinical trials are essential for producing accurate intervention effica...
Oral emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) has been evaluated as pre-exposure prophy...
Low adherence in vaginal microbicide clinical trials for HIV prevention has impeded interpretation o...
The Author(s) 2014. This article is published with open access at Springerlink.com Abstract Oral emt...
Accurate estimates of study product use are critical to understanding and addressing adherence chall...
Accurate estimates of study product use are critical to understanding and addressing adherence chall...
Objectives: In VOICE, a phase IIB trial of daily oral and vaginal tenofovir for HIV prevention, at l...
VOICE—a phase 2B, placebo-controlled, randomized trial testing daily use of an antiretroviral tablet...
BackgroundInterpretation of clinical trial results testing vaginal microbicide gels for HIV preventi...
This mixed-methods study used qualitative interviews to explore discrepancies between self-reported ...
Background Subjects who enroll in multiple studies have been found to use decep-tion at times to ove...
High levels of adherence in clinical trials are essential for producing accurate intervention effica...
Disclosure, or open communication, by female microbicide trial participants of their trial participa...
The goal of this study was to explore patterns and explanations of adherence to antiretroviral thera...
Misreporting of adherence undermines detection of an association between product use and HIV infecti...
High levels of adherence in clinical trials are essential for producing accurate intervention effica...
Oral emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) has been evaluated as pre-exposure prophy...
Low adherence in vaginal microbicide clinical trials for HIV prevention has impeded interpretation o...
The Author(s) 2014. This article is published with open access at Springerlink.com Abstract Oral emt...